| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $19.5M | +2.7% |
| SG&A Expense | $10.0M | -13.2% |
| Operating Income | -$29.6M | +3.3% |
| Income Tax | $0 | — |
| Net Income | -$29.8M | -2.6% |
| EPS (Basic) | -$15.07 | -1392.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.6M | -45.4% |
| Current Assets | $26.3M | -42.4% |
| Total Assets | $38.2M | -33.4% |
| Current Liabilities | $6.8M | +41.4% |
| Total Liabilities | $12.1M | +132.2% |
| Stockholders' Equity | $26.1M | -50.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.1M | +12.8% |
| Capital Expenditures | $124K | +85.1% |
| Investing Cash Flow | -$124K | -85.1% |
| Financing Cash Flow | $4.7M | — |
| Free Cash Flow | -$24.2M | +12.6% |